
Pfizer Prepares to Divest Final Share of Haleon as Strategic Shift Takes Shape
Pfizer Inc. is making significant moves as it aims to fully divest its stake in Haleon, the consumer healthcare business it previously shared with GlaxoSmithKline (GSK). The pharmaceutical giant has announced plans to execute a final sale of its shareholding in Haleon, a move that signifies a strategic shift as Pfizer refocuses on enhancing its core pharmaceutical and vaccine operations.
Continue reading
UK Engineering Giant Smiths Group Plans Major Breakup Amid Activist Investor Pressure
In a significant strategic shift, Smiths Group, a prominent UK engineering company, has announced plans to break itself up. This decision comes in response to mounting pressure from activist investors who have long been advocating for a reevaluation of the company's structure and operations. The firm, known for its diverse portfolio that includes advanced technology products, medical devices, and detection systems, aims to enhance shareholder value through this daring move.
Continue reading
Leadership Shake-Up at Société Générale: Deputy CEO Aymerich and CFO Dumas to Depart
In a surprising move that is set to reshape the executive landscape at Société Générale, both Deputy CEO Pierre Aymerich and Chief Financial Officer (CFO) Slawomir Dumas are preparing to leave their positions. The announcement marks a significant shift in the French banking giant’s leadership strategy as it navigates the challenging financial markets and restructures its operational framework.
Continue reading